Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Non Operating Income (2016 - 2025)

Veracyte (VCYT) has disclosed Non Operating Income for 14 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 569.81% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2025, up 8.56% year-over-year, with the annual reading at $10.4 million for FY2025, 8.56% up from the prior year.
  • Non Operating Income hit $3.4 million in Q4 2025 for Veracyte, up from -$4.1 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.5 million in Q2 2025 to a low of -$4.1 million in Q3 2025.
  • Historically, Non Operating Income has averaged $1.7 million across 5 years, with a median of $1.6 million in 2021.
  • Biggest YoY gain for Non Operating Income was 3528.57% in 2021; the steepest drop was 1985.71% in 2021.
  • Year by year, Non Operating Income stood at $1.0 million in 2021, then soared by 94.78% to $2.0 million in 2022, then soared by 154.42% to $5.0 million in 2023, then plummeted by 114.54% to -$732000.0 in 2024, then surged by 569.81% to $3.4 million in 2025.
  • Business Quant data shows Non Operating Income for VCYT at $3.4 million in Q4 2025, -$4.1 million in Q3 2025, and $6.5 million in Q2 2025.